Suchit K. Amin has filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, regarding his acquisition of equity shares in Archit Organosys Limited. The transaction was completed on March 19, 2026, through open market purchase.

Share Acquisition Details

The acquisition involved 4,263 equity shares, representing 0.02% of the company's total share capital. This transaction increased Amin's total shareholding in the company from his previous position.

Promoter Group Information

Suchit Kandarp Amin belongs to the promoter group of Archit Organosys Limited. The disclosure identifies several persons acting in concert (PAC) with the acquirer:

• Kandarp Amin
• Archana Amin
• Archit Amin
• Shimoli Amin
• Manini Amin

Company Share Capital Structure

The company's equity share capital structure remained unchanged following this transaction:

Transaction Specifics

The acquisition was executed through open market purchase on March 19, 2026. The disclosure confirms that no shares were encumbered, and no voting rights were acquired otherwise than by shares. Additionally, no warrants, convertible securities, or other instruments entitling the acquirer to receive shares carrying voting rights were involved in this transaction.

The filing indicates that the acquirer held no encumbrances such as pledges, liens, or non-disposal undertakings both before and after the acquisition. The total diluted share capital of the company remains at Rs. 20,52,07,230, consisting of 2,05,20,723 equity shares of Rs. 10 each.

Archit Organosys Limited has executed a Banakhat agreement for the acquisition of land from its promoter-director for Rs. 10.51 crore. The company informed BSE Limited about this significant related party transaction on March 17, 2026, in compliance with regulatory requirements.

Transaction Details

The land purchase transaction involves specific parameters that highlight the scope and nature of the acquisition:

Regulatory Compliance

The transaction has been structured in accordance with SEBI regulations governing related party transactions. The company obtained necessary approvals from its Audit Committee and Board of Directors before proceeding with the land acquisition. This compliance framework ensures transparency in dealings between the company and its promoter-director.

Archit Organosys Limited had previously intimated the exchange about this proposed transaction on February 21, 2026, demonstrating proactive disclosure practices. The company has committed to providing further updates upon execution of the Conveyance Deed/Sale Deed.

Future Disclosures

The company will share additional details as required under SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 upon execution of the Conveyance Deed. This ensures complete regulatory compliance and maintains transparency with stakeholders regarding the land acquisition process.

The transaction represents a significant corporate development for Archit Organosys Limited, involving substantial capital deployment for land acquisition in Gujarat's Bhavnagar district.